Naturally Occurring Clostridium perfringens Nontoxic Alpha-Toxin Variant as a Potential Vaccine Candidate against Alpha-Toxin-Associated Diseases

AUTOR(ES)

Schoepe, Heike

FONTE

American Society for Microbiology

RESUMO

Clostridium perfringens mutant strain 121A/91 shows neither enzymatic (phospholipase C) nor hemolytic activity. Nevertheless, the cpa gene and the corresponding alpha-toxin variant are detectable. Vaccination with this genetically constructed alpha-toxin variant, rAT121/91, induces antibodies capable of significantly reducing activities induced by wild-type toxin. Thus, rAT121/91 could be a useful vaccine candidate.

Documentos Relacionados

• Epitope mapping of the alpha-toxin of Clostridium perfringens.
• Highly Conserved Alpha-Toxin Sequences of Avian Isolates of Clostridium perfringens
• Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringens.
• Synergistic Effects of Alpha-Toxin and Perfringolysin O in Clostridium perfringens-Mediated Gas Gangrene
• Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis.